Oral candidiasis from ICS — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Assess for oral candidiasis and consider antifungal treatment pathway
This scenario assesses Oral candidiasis from ICS in a UK pharmacy practice context. ICS use predisposes to oral candidiasis, and assessment plus mouth-rinsing and technique advice are needed. The best answer is Assess for oral candidiasis and consider antifungal treatment pathway because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.
Reference: BNF; NICE CKS